相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-sensitive C-reactive protein: universal prognostic and causative biomarker in heart disease?
Ernst Rietzschel et al.
BIOMARKERS IN MEDICINE (2012)
Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Association of lower total bilirubin level with statin usage: The United States National Health and Nutrition Examination Survey 1999-2008
Kwok Leung Ong et al.
ATHEROSCLEROSIS (2011)
Relationship between bilirubin and C-reactive protein
Hee-Jin Hwang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years
K. L. Ong et al.
DIABETOLOGIA (2011)
Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?
Pernette R. W. de Sauvage Nolting et al.
JOURNAL OF LIPID RESEARCH (2011)
Utilization of lipid lowering medications among adults in the United States 1999-2006
Mingfang Li et al.
ATHEROSCLEROSIS (2010)
Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease
Jing-Ping Lin et al.
CLINICAL CHEMISTRY (2010)
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
Brent M. Egan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
Bernard M. Y. Cheung et al.
AMERICAN JOURNAL OF MEDICINE (2009)
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations
Jacques Genest et al.
CANADIAN JOURNAL OF CARDIOLOGY (2009)
Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006
Elena V. Kuklina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a US Population Insights From the ARIC (Atherosclerosis Risk in Communities) Study
Eric Y. Yang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Paul M. Ridker
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M. Ridker et al.
LANCET (2009)
Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: Results from the MONICA/KORA Augsburg cohort study, 1984-1998
Wolfgang Koenig et al.
CLINICAL CHEMISTRY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity
Paul M Ridker
NUTRITION REVIEWS (2008)
Is glycemic control improving in US adults?
Thomas J. Hoerger et al.
DIABETES CARE (2008)
Peripheral Vascular Disease - Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension
Anoop Shankar et al.
AMERICAN HEART JOURNAL (2007)
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004
Kwok Leung Ong et al.
HYPERTENSION (2007)
Valsartan, blood pressure reduction, and C-reactive protein - Primary report of the Val-MARC trial
Paul M. Ridker et al.
HYPERTENSION (2006)
Medical progress - Assessing kidney function - Measured and estimated glomerular filtration rate
Lesley A. Stevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
CM Ballantyne et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men:: a population-based cohort study
DE Laaksonen et al.
EUROPEAN HEART JOURNAL (2005)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Simvastatin induces heme oxygenase-1 - A novel mechanism of vessel protection
TS Lee et al.
CIRCULATION (2004)
A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the ADET trial
M Woodward et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Relationship between effects of statins, aspirin and anglotensin II modulators on high-sensitive C-reactive protein levels
T Takeda et al.
ATHEROSCLEROSIS (2003)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
A Festa et al.
CIRCULATION (2000)
分享论文
